Overview A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) Status: Recruiting Trial end date: 2024-06-01 Target enrollment: Participant gender: Summary A clinical study to evaluate the long-term safety of Sodium Oligomannate Capsules (GV-971) Phase: Phase 4 Details Lead Sponsor: Shanghai Greenvalley Pharmaceutical Co., Ltd.